Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activity

Cell Microbiol. 2002 Sep;4(9):599-611. doi: 10.1046/j.1462-5822.2002.00214.x.

Abstract

A major problem in the development of vaccines against Gram-negative bacteria is the endotoxic -activity of lipopolysaccharide (LPS), which is determined by its lipid A moiety. Nevertheless, LPS would be an interesting vaccine component because of its immune-stimulating properties. In the present study, we have changed the fatty acid composition of Neisseria meningitidis LPS by replacing the lpxA gene of strain H44/76 with the Escherichia coli or Pseudomonas aeruginosa homologue. The majority of the O-linked 3-OH C12 in N. meningitidis lipid A was replaced by 3-OH C14 (strain HA01E) and 3-OH C10 (strain HA25P) respectively. Both strains, but most notably strain HA01E, had reduced amounts of LPS compared with the wild-type strain. In addition, growth was severely impaired for HA01E. The major outer membrane proteins were expressed normally. Outer membrane complexes of both strains normalized on their LPS content showed a 10-fold reduction in their ability to induce tumour necrosis factor (TNF)-alpha. Immunogenicity studies in BALB/c mice revealed that the adjuvant activity of the LPS was not affected. Thus, the replacement of the O-linked fatty acids in meningococcal lipid A results in immunogenic outer membranes with reduced endotoxic activity, more suitable for use in outer membrane vesicle vaccines.

Publication types

  • Comparative Study

MeSH terms

  • Acyltransferases / genetics
  • Acyltransferases / metabolism*
  • Adjuvants, Immunologic / metabolism*
  • Bacitracin / pharmacology
  • Fatty Acids / metabolism
  • Gene Transfer Techniques
  • Lipid A / biosynthesis*
  • Lipid A / chemistry
  • Lipid A / metabolism
  • Lipid A / toxicity*
  • Meningococcal Vaccines / immunology
  • Neisseria meningitidis / drug effects
  • Neisseria meningitidis / enzymology*
  • Neisseria meningitidis / genetics*
  • Neisseria meningitidis / metabolism
  • Neisseria meningitidis / ultrastructure
  • Novobiocin / pharmacology
  • Recombinant Proteins / metabolism*
  • Rifampin / pharmacology
  • Tetracycline / pharmacology
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Adjuvants, Immunologic
  • Fatty Acids
  • Lipid A
  • Meningococcal Vaccines
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Bacitracin
  • Novobiocin
  • Acyltransferases
  • acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase
  • Tetracycline
  • Rifampin